Security key
51654W101
Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (LTRN)
CUSIP: 51654W101
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 32,866
- Total 13F value
- $33,195
- Share change
- -1,923
- SEC-reported price per share
- $1.01
- Number of holders
- 3
- Value change
- -$1,942
- Number of buys
- 1
- Number of sells
- 1
- Shares outstanding
- 15,148,116
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
3
Top holders
3
LTRN full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
Lantern Pharma Inc. SEC filings
Lantern Pharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 51654W101
Recent filing periods:
Ownership snapshot
Top reported holders of LTRN - Lantern Pharma Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Thomas A. Satterfield Jr.
Disclosed value leader
Thomas A. Satterfield Jr.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.6%
13D/G row: Thomas A. Satterfield Jr.
Showing 1-6 of 15 holder rows.
Quick read
Thomas A. Satterfield Jr. leads the comparable SEC ownership view at 7.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Thomas A. Satterfield Jr.'s linked filing trail.
Comparable ownership
Top 5
Thomas A. Satterfield Jr.
7.6%
Empery Asset Management, LP
5%
Bios Equity Partners, LP
4.5%
Aaron G.l. Fletcher
7.1%
Leslie W. Kreis
7.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Thomas A. Satterfield Jr. |
13D/G
|
7.6%
|
$4,065,750
975,000 shares
|
+$1,688,850 | 30 Jun 2026 |
| Empery Asset Management, LP |
13F
13D/G
Company
|
5%
from 13D/G
|
$3,513,930
842,669 shares
|
— | 30 Jun 2026 |
| Bios Equity Partners, LP |
13D/G
BIOS ADVISORS GP, LLC
|
4.5%
|
$1,125,471
571,305 shares
|
-$518,991 | 15 May 2026 |
| Aaron G.l. Fletcher |
3/4/5
10%+ Owner
|
7.1%
|
$3,344,781
1,075,952 shares
|
— | 13 Jun 2025 |
| Leslie W. Kreis |
3/4/5
10%+ Owner
|
7.1%
|
$3,344,781
1,075,952 shares
|
— | 13 Jun 2025 |
| CM Management, LLC |
13F
Company
|
3.3%
|
$2,085,000
500,000 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
32,866
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
39
Q3 2026 holders
3
Holder diff
-36
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend